Ethyl Acetate

Ethyl Acetate

SCHEMBL4899372

CC(C)C(C)(OC(C)(C(C)C)C(C)C)C(C)C.CCOC(C)=O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
LMNA P02545 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TSHR P16473 1/20 0.39
MMP8 P22894 1/20 0.37
GAA P10253 2/20 0.34
ALOX15 P16050 1/20 0.34
MGAM O43451 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
CTSK P43235 1/20 0.33
PKM P14618 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLO1 Q04760 1/20 0.32
TRPA1 O75762 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
THRB P10828 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL3986904 0.79 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10TSHRMMP8
Ethyl Acetate SCHEMBL14912846 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL17329136 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL631255 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL3227893 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL6544500 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL2210248 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL18725338 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1428083 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL15420019 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080167347-A1 Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives SHIONGI & CO., LTD. (JP) 2008-07-10 US disclosed
EP-1839655-A1 CTGF EXPRESSION INHIBITOR Shionogi Co., Ltd. (JP) 2007-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167347-A1 Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives CCNY, HDGF, GLI1 ALDH1A1 1472/4885LMNA 2426/4885HSD17B10 1858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.